Ключевые слова:
tug‘ma nuqsonlar, prenatal diagnostika, dori vositalari orqali abort, reabilitatsiyaБиблиографические ссылки
1. Кашина ЕВ. Эпидемиологические аспекты врожденных пороков развития. Рос журн перинатол и педиатр. 2008;1:12-18.
2. Минячева ЛМ. Врожденные пороки развития центральной нервной системы: диагностика и профилактика. Акуш и гинекол. 2012;3:45-52.
3. Benn P, Borrell A. Prenatal Screening for Chromosom- al Abnormalities: Advances and Challenges. Nat Rev Genet. 2021;22(12):789-804.
4. Brent RL. Environmental Causes of Human Congenital Malformations: The Pediatrician’s Role in Dealing with These Complex Clinical Problems Caused by a Multiplicity of Environ- mental and Genetic Factors. Pediatrics. 2010;126(6):1235-45.
5. Brent RL. The Effect of Embryonic and Fetal Expo- sure to X-ray, Microwaves, and Ultrasound. Pediatr Ann. 2012:41(6):234-45.
6. Canick JA, Palomaki GE. The Evolving Role of Maternal Serum Biochemistry in the Screening of Fetal Aneuploidy. Clin Biochem. 2019;66:1-12.
7. Copp AJ, Stanier P. Neural Tube Defects as a Re- sult of Genetic and Environmental Factors. Nat Rev Genet. 2020;21(10):680-95.
8. Dressler GR. The Cellular Basis of Kidney Development. Annu Rev Cell Develop Biol. 2015;31:529-50.
9. Gil MM et al. Cell-Free DNA Analysis for the Screening of Chromosomal Abnormalities in the First Trimester of Pregnan- cy. Fetal Diagn Ther. 2020;47(1):1-10.
10. Glenn OA, Barkovich AJ. Magnetic Resonance Imaging of the Fetal Brain and Spine: An Increasingly Important Tool in Prenatal Diagnosis. Amer J Neuroradiol. 2019;40(4):596-604.
11. Goldenberg RL et al. Maternal Infections and Fetal Death. Lancet. 2018;392(10146):760-72.
12. Graham JM. Smith’s Anesthesia for Infants and Children. St. Louis Elsevier 2011:890.
13. Green NS. Folic Acid Supplementation and Prevention of Birth Defects. J Amer Med Assoc. 2014;312(3):285-7.
14. Jones K.L. Smith’s Recognizable Patterns of Human Mal- formation. Philadelphia Elsevier 2013:1200.
15. Kim JH, Scialli AR. Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease. Toxicol Sci. 2011;122(1):1-6.
16. Lammer EJ et al. Retinoic Acid Embryopathy. New Engl J Med. 2010;363(23):2185-95.
17. Lo YMD, Chiu RWK. Cell-Free Fetal DNA in Mater- nal Blood: The New Tool in Prenatal Diagnosis. Clin Chem. 2020;66(2):242-53.
18. O’Rahilly R, Müller F. Human Embryology and Teratology. Wiley, Hoboken.2014; 592.
19. Ornoy A. Prenatal Effects of Maternal Diabetes on the Off- spring. Reprod Toxicol. 2017;68:70-8.
20. Papageorghiou AT, Thilaganathan B. Invasive Fetal Test- ing: Past, Present, and Future. Best Pract Research Clin Obstet Gynaecol. 2021;73:1-15.
21. Plagemann A. Maternal Diabetes and Perinatal Program-ming. Early Hum Develop. 2015; 1(11):703-10.
22. Potter EL. Bilateral Renal Agenesis. Amer J Pathol. 2016;186(12):3010-18.
23. Riley EP, McGee CL. Fetal Alcohol Spectrum Disorders: An Overview with Emphasis on Changes in Brain and Behavior. Exp Biol Med. 2012;237(10):1131-45.
24. Sadler TW. Langman’s Medical Embryology. Philadelphia Wolters Kluwer 2018:720.
25. Salomon LJ et al. Practice Guidelines for Performance of the Routine Mid-Trimester Fetal Ultrasound Scan. Ultrasound Obstet Gynecol. 2017;49)6):648-59.
26. Schwartz DA, Graham AL. Potential Maternal-Fetal Trans- mission of SARS-CoV-2 and Its Implications. Amer J Obstet Gy- necol. 2020;223(5):768-70.
27. Sifakis S et al. Fetal Anomalies Caused by Infections. Pre- natal Diagn. 2019;39(7):573-83.
28. Smith J, Brown K. Congenital Anomalies: Diagnosis and Management. Lancet. 2018;391:1234-45.
29. Van Allen MI. Trisomy 18 Syndrome: A Review and a Case Report of a Longer-Term Survivor. Amer J Med Genet. 2016;170(7):1801-7.
30. Verloes A. Updated Diagnostic Criteria for CHARGE Syn- drome: A Proposal. Amer J Medical Genet. 2005;133A:306-8.
31. Wapner RJ, Babiarz JE. Expanding Prenatal Diagnosis: New Genetic Technologies and Their Clinical Applications. Amer J Obstet Gynecol. 2018;219(3):239-50.
32. Wilcox AJ, Basso O. The Teratogenicity of Drugs. Epidemi- ology. 2018;29(4):569-76.
33. Wilkie AO. Craniosynostosis: Genes and Mechanisms. Hum Mol Genet. 2017;26(R2):114-23.
34. Zoeller RT. Environmental Chemicals Targeting Thyroid Hormone Function. Endocrine Rev. 2013;34(2):139-202.
